Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
HRP20191812T1 - Derivat 6,7,8,9-tetrahidro-3h-pirazolo[4,3-f]izokinolina koristan u liječenju raka - Google Patents
[go: Go Back, main page]

HRP20191812T1 - Derivat 6,7,8,9-tetrahidro-3h-pirazolo[4,3-f]izokinolina koristan u liječenju raka - Google Patents

Derivat 6,7,8,9-tetrahidro-3h-pirazolo[4,3-f]izokinolina koristan u liječenju raka Download PDF

Info

Publication number
HRP20191812T1
HRP20191812T1 HRP20191812TT HRP20191812T HRP20191812T1 HR P20191812 T1 HRP20191812 T1 HR P20191812T1 HR P20191812T T HRP20191812T T HR P20191812TT HR P20191812 T HRP20191812 T HR P20191812T HR P20191812 T1 HRP20191812 T1 HR P20191812T1
Authority
HR
Croatia
Prior art keywords
cancer
pyrazolo
tetrahydro
treatment
pharmaceutically acceptable
Prior art date
Application number
HRP20191812TT
Other languages
English (en)
Croatian (hr)
Inventor
James Stewart Scott
Bernard Christophe Barlaam
Bin Yang
Thomas Andrew Moss
Samantha Jayne Hughes
Johannes Wilhelmus Maria Nissink
Daniel Hillebrand O'donovan
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority claimed from PCT/EP2017/076191 external-priority patent/WO2018077630A1/en
Publication of HRP20191812T1 publication Critical patent/HRP20191812T1/hr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HRP20191812TT 2016-10-24 2017-10-13 Derivat 6,7,8,9-tetrahidro-3h-pirazolo[4,3-f]izokinolina koristan u liječenju raka HRP20191812T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662411799P 2016-10-24 2016-10-24
PCT/EP2017/076191 WO2018077630A1 (en) 2016-10-24 2017-10-13 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline derivatives useful in the treatment of cancer
EP17783857.0A EP3433256B1 (en) 2016-10-24 2017-10-13 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline derivative useful in the treatment of cancer

Publications (1)

Publication Number Publication Date
HRP20191812T1 true HRP20191812T1 (hr) 2019-12-27

Family

ID=65728648

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20191812TT HRP20191812T1 (hr) 2016-10-24 2017-10-13 Derivat 6,7,8,9-tetrahidro-3h-pirazolo[4,3-f]izokinolina koristan u liječenju raka

Country Status (3)

Country Link
AR (1) AR109951A1 (sr)
HR (1) HRP20191812T1 (sr)
RS (1) RS62937B1 (sr)

Also Published As

Publication number Publication date
AR109951A1 (es) 2019-02-06
RS62937B1 (sr) 2022-03-31

Similar Documents

Publication Publication Date Title
HRP20250250T1 (hr) Derivati 7‑benzil‑4‑(2‑metilbenzil)‑2,4,6,7,8,9‑heksahidroimidazo[1,2‑a]pirido[3,4‑e] pirimidin‑5(1h)‑ona, njihove soli i njihova upotreba u terapiji
HRP20250191T1 (hr) Derivati 3-(kinolin-8-il)-1,4-dihidropirido[3,4-d]pirimidin-2,4-diona kao inhibitori alfa4beta7 integrina za liječenje upalnih bolesti
PH12019500830A1 (en) 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline derivatives useful in the treatment of cancer
EP3500575A4 (en) CRYSTALLINE FORM OF ((S) -7- (1-ACRYLOYLPIPERIDIN-4-YL) -2- (4-PHENOXYPHENYL) -4,5,6,7-TETRA-HYDROPYRAZOLO [1,5-A] PYRIMIDIN-3- CARBOXAMIDE, PRODUCTION AND USE THEREOF
EA201890852A1 (ru) Соли валбеназина и их полиморфы
WO2015010078A3 (en) Substituted 6,5-fused bicyclic heteroaryl compounds
HRP20201812T1 (hr) Modulatori proteina jezgre hepatitisa b
LT3174875T (lt) (4s)-4-(4-ciano-2-metoksifenil)-5-etoksi-2,8-dimetil-1,4-dihidro-1,6-naftiridin-3-karboksamido gavimo būdas ir jo, skirto naudoti kaip aktyvų farmacinį ingredientą, gryninimas
WO2016142855A3 (en) Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
IL227990B (en) Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2,6-dione for preparation of medicaments for treatment of immune-related and inflammatory diseases
EA201690093A1 (ru) Производные пирроло[3,2-d]пиримидина для лечения вирусных инфекций и других заболеваний
PH12016502168B1 (en) Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
MX377305B (es) DERIVADOS DE IMIDAZO[4,5-c]QUINOLINA E IMIDAZO[4,5-c][1,5]NAFTIRIDINA NOVEDOSOS COMO INHIBIDORES DE LRRK2.
MX2015012432A (es) Inhibidores piridinicos de la cinasa cdk9.
CL2015003444A1 (es) Compuestos de 3,4 dihidroisoquinolin-2(1h)-ilo
HUE057549T2 (hu) Imidazo[1,2-a]pirimidinszármazékok, eljárás elõállításukra és alkalmazásaik
HUE052332T2 (hu) Heteroaril-származék vagy gyógyászatilag elfogadható sója, eljárás annak elõállítására, és az ezeket hatóanyagént tartalmazó gyógyászati készítmény PI3 kinázokkal összefüggõ betegségek megelõzésére vagy kezelésére
ZA202105976B (en) Pharmaceutical dosage form for application to mucous membranes and methods for producing same
HRP20211653T1 (hr) 7-benzil-4-(2-metilbenzil)-2,4,6,7,8,9-heksahidroimidazo[1,2-a]pirido[3,4-e]pirimidin-5(1h)-on, njegove soli i postupci korištenja istih u kombiniranoj terapiji
MY179605A (en) Use of benzimidazole-proline derivatives
EP3546458A4 (en) PYRIDO [3,4-D] PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL ACCEPTABLE SALT THEREOF
EP3307239A4 (en) FORMULATIONS FOR RELEASE OF RSV AND NOROVIRUS ANTIGENES IN THE THINNER
HRP20211107T1 (hr) Mimetici obrambenih proteina domaćina, namijenjeni profilaksi i/ili liječenju upalnih bolesti gastrointestinalnog sustava
HRP20201187T1 (hr) Derivat triazolopirazinona koristan kao inhibitor ljudskog pde1
WO2015160907A3 (en) Potent and selective inhibitors of hepatitis c virus